BOSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (NASDAQ: RDUS) provided an update on the abaloparatide transdermal system (abalo-TDS) development program. As ...

Patients and prescribers alike are familiar with the vast array of psychiatric medicines available to treat mental illnesses. They are often less aware that certain psychotropics can be delivered via ...

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue The FDA has approved Purdue's Butrans (buprenorphine) Transdermal System for the management of moderate to severe ...

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function More than 800 million people have Chronic ...

Several transdermal products and applications include hormone replacement therapy, contraception, management of pain, angina pectoris, smoking cessation and neurological disorders such as Parkinson's ...

BUTRANS (buprenorphine) 5mcg/hr, 10mcg/hr, 20mcg/hr transdermal patch by Purdue Purdue announced that Butrans (buprenorphine) Transdermal System will be available for ordering the week of January 10, ...

POTTERS BAR, England and PITTSBURGH, March 11, 2015 /PRNewswire/ -- Mylan N.V. (MYL) and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, ...

Purpose: The efficacy and safety of fentanyl hydrochloride patient-controlled trans-dermal system (PCTS) for management of acute postoperative pain are discussed. Summary: Fentanyl hydrochloride PCTS ...

The approval granted by the US Food and Drug Administration (USFDA) is to market the Scopolamine transdermal system of dosage 1 mg/3 days, Zydus Lifesciences said in a regulatory filing. New Delhi: ...

Zydus Lifesciences Limited (including its subsidiaries/affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...

Transdermal drug delivery is valued by patients and physicians for the comfort and convenience it offers — no needles, no pills and ease of use Transdermal drug delivery is valued by patients and ...

Dermatitis. 2006;17(3):109-122. In 1985, Maibach reported a series of trials performed to determine both the irritation and sensitization potential of clonidine and clonidine TTSs. The irritation ...